Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06367998Phase 4Not yet recruiting
A Phase 4 trial of pregabalin in Central sensitization (CS), myofascial pain syndrome (MPS), shoulder pain, sponsored by The Catholic University of Korea. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06367998.